Guru Ownership Trend
Guru Analysis for Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $45.14 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $7.99 M net outflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 43.1%. Conversely, Cliff Asness reduced exposure by 30.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Kura Oncology, Inc. (KURA)
Major holders include Cliff Asness ($17.27 M), Renaissance Technologies (RenTech) ($12.87 M), Ken Fisher ($5.49 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 4.43 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $7.99 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited KURA. The total reported sell value was $9.64 M.
Yes, 0 managers opened new positions in KURA, and 1 increased their existing holdings. The total reported buy value was $1.65 M.